| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/09/2011 | US20110135608 Use of probiotic bacteria for the treatment of hyperhomocysteinaemia |
| 06/09/2011 | US20110135594 Oxindolyl inhibitor compounds |
| 06/09/2011 | DE102009056746A1 Transdermales therapeutisches System für die Verabreichung von Peptiden Transdermal therapeutic system for the administration of peptides |
| 06/09/2011 | CA2818233A1 Salacinol and ponkoranol homologues, derivatives thereof, and methods of synthesizing same |
| 06/09/2011 | CA2782727A1 2-pyridone compounds |
| 06/09/2011 | CA2782691A1 Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| 06/09/2011 | CA2782380A1 Liquid compositions comprising vitamin d and uses thereof |
| 06/09/2011 | CA2780921A1 Method of regulating ppar, obesity related pathways and their associated metabolic impact |
| 06/09/2011 | CA2780219A1 Azacyclic spiro derivatives |
| 06/08/2011 | EP2330219A2 Method for drug discovery, disease treatment and diagnosis using metabolomics |
| 06/08/2011 | EP2330197A2 Antagonistic selective binding agents of osteoprotegerin binding protein |
| 06/08/2011 | EP2330193A1 Improved antibody molecule |
| 06/08/2011 | EP2330187A2 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic diseases |
| 06/08/2011 | EP2330127A2 Kallikrein-inhibiting Kunitz Domain proteins and nucleic acids encoding the same |
| 06/08/2011 | EP2330103A1 Novel epigallocatechin gallate tetramer, and vascular endothelial function improver comprising same |
| 06/08/2011 | EP2330098A1 Compound with agitation effect on peroxisome proliferator-activated receptor , and preparation method and use thereof |
| 06/08/2011 | EP2330092A2 Medicament comprising steviol or isosteviol for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome |
| 06/08/2011 | EP2329839A1 Modification of feeding behavior by GLP-1 and PYY |
| 06/08/2011 | EP2329836A1 Extracts obtained from hoodia gordonii cells lines, their preparation and use |
| 06/08/2011 | EP2329830A2 Antisense inhibition of PTP1B expression |
| 06/08/2011 | EP2329828A1 Tetracyclines for the treatment of ischaemia |
| 06/08/2011 | EP2329826A1 Tetracyclines for the treatment of multiple sclerosis |
| 06/08/2011 | EP2329820A1 Pharmaceutical composition for treating hypertension and metabolic syndrome and use thereof |
| 06/08/2011 | EP2328897A1 Bicyclic heterocycle derivatives and their use as gpcr modulators |
| 06/08/2011 | EP2328892A1 Oxotetrahydrofuran-2-yl-benzimidazole derivative |
| 06/08/2011 | EP2328889A1 Acetyl pyrrolidinyl indole derivative |
| 06/08/2011 | EP2328886A1 Derivatives of triazines and uracils, their preparation and their application in human therapeutics |
| 06/08/2011 | EP2328874A2 Compounds, compositions and methods of using same for modulating uric acid levels |
| 06/08/2011 | EP2328873A2 Preparation of ranolazine |
| 06/08/2011 | EP2328867A1 Heterocyclic gpcr agonists |
| 06/08/2011 | EP2328858A1 Hydroxybutyrate ester and medical use thereof |
| 06/08/2011 | EP2328608A2 Use of ultrarapid acting insulin |
| 06/08/2011 | EP2328570A2 Method and formulation for treating adverse biological conditions |
| 06/08/2011 | EP2207770B1 1, 2, 3-triazole derivatives for use as stearoyl-coa desaturase inhibitors |
| 06/08/2011 | EP2044054B1 Pyrimidine and quinazoline derivatives as modulators of somatostatine receptor activity |
| 06/08/2011 | EP1427427B1 Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 06/08/2011 | EP1320356B2 Preparation of vitamin emulsions and concentrates thereof |
| 06/08/2011 | CN1882524B 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 06/08/2011 | CN102089301A Piperidine gpcr agonists |
| 06/08/2011 | CN102089299A Piperidinyl gpcr agonists |
| 06/08/2011 | CN102089298A Heterocyclic gpcr agonists |
| 06/08/2011 | CN102089291A Cyclopentylacrylic acid amide derivative |
| 06/08/2011 | CN102089287A Tetrahydrocinnolines as 11 beta HSD1 inhibitors for diabetes |
| 06/08/2011 | CN102089283A Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group |
| 06/08/2011 | CN102089281A Novel indole derivative having carbamoyl group, ureide group and substituted oxy group |
| 06/08/2011 | CN102089277A Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same |
| 06/08/2011 | CN102088995A Use of angiogenin or angiogenin agonists for treating diseases and disorders |
| 06/08/2011 | CN102088988A Methods for the treatment or prevention of diabetes mellitus and other metabolic imbalances |
| 06/08/2011 | CN102088986A Large-scale process for the preparation of thylakoids |
| 06/08/2011 | CN102088978A Ameliorating or therapeutic agent for dyslipidemia |
| 06/08/2011 | CN102088965A Salicylate conjugates useful for treating metabolic disorders |
| 06/08/2011 | CN102087249A Quality control method for insulin inhalation powder |
| 06/08/2011 | CN102086236A Method for extracting and separating in vivo alkali-soluble polysaccharide from old water shield leaves |
| 06/08/2011 | CN102086197A Protoberberine derivative with insulin-sensitizing activity and application thereof |
| 06/08/2011 | CN102086184A 5-fluorine-substituted 4-hydroxyl-3,4,5,6-tetrahydro-2H-pyrane-2-ketone compound and preparation method thereof |
| 06/08/2011 | CN102086172A Medicinal salts of saxagliptin and preparation methods of medicinal salts |
| 06/08/2011 | CN102085372A Application of Notch pathway inhibitor in treatment of tumors caused by activation of mTOR |
| 06/08/2011 | CN102085355A Liraglutide long-acting microsphere injection and preparation method thereof |
| 06/08/2011 | CN102085348A Preparation method and application of compound radix bupleuri preparation |
| 06/08/2011 | CN102085309A Medicinal composition for treating diabetes |
| 06/08/2011 | CN102085305A Dripping pill capable of reducing fat |
| 06/08/2011 | CN102085304A Blood-sugar-reducing capsules |
| 06/08/2011 | CN102085281A Medicinal composition having effect of reducing weight |
| 06/08/2011 | CN102085250A Goldthread root dispersible tablets |
| 06/08/2011 | CN102085243A Medicament for treating diabetic foot |
| 06/08/2011 | CN102085242A Common fig health-care capsules |
| 06/08/2011 | CN102085236A Oral liquid for helping reduce blood fat |
| 06/08/2011 | CN102085232A Astragalus dispersible tablets |
| 06/08/2011 | CN102085230A Balloonflower dispersible tablets |
| 06/08/2011 | CN102085227A Preparation with function of reducing blood sugar and preparation method thereof |
| 06/08/2011 | CN102085226A Japanese picris japonica extract and extracting method thereof |
| 06/08/2011 | CN102085222A Method for preparing Shuxuening injection |
| 06/08/2011 | CN102085216A High-density calcium carbonate tablet and preparation method thereof |
| 06/08/2011 | CN102085200A New applications of compound mycoE |
| 06/08/2011 | CN102085192A Rosuvastatin calcium oral disintegrating tablet and preparation method thereof |
| 06/08/2011 | CN102085186A Glycyrrhetinic acid emulsion and preparation method thereof |
| 06/08/2011 | CN102085184A Preparation of fotemustine fat emulsion for injection |
| 06/08/2011 | CN102085181A Lovastatin nano crystallization preparation and method for preparing same |
| 06/08/2011 | CN101822662B Application of 9,10-dioxystearic acid (DHSA) in preparing medicaments for preventing and treating diabetes |
| 06/08/2011 | CN101810660B Water-soluble silymarin and preparation method thereof |
| 06/08/2011 | CN101766578B Tablet containing Rosuvastatin calcium and preparation process thereof |
| 06/08/2011 | CN101757019B Medical composition for losing weight or treating metabolic syndromes |
| 06/08/2011 | CN101721365B Levulose liposome injection and novel application thereof |
| 06/08/2011 | CN101708160B Pamidronate disodium suspension injection |
| 06/08/2011 | CN101642529B Preparation capable of treating diabetes |
| 06/08/2011 | CN101637457B Preparation method for cerebroprotein hydrolysate freeze-dried injection for injection |
| 06/08/2011 | CN101569692B Compound health herb tea |
| 06/08/2011 | CN101491635B Chinese medicine composition for treating diabetes |
| 06/08/2011 | CN101444486B Water-soluble drug sustained-release microsphere and preparation method and applications thereof |
| 06/08/2011 | CN101433592B Preparation method of Lupulus extract containing xanthohumol |
| 06/08/2011 | CN101391101B New use of cyclodextrin glucanotransferase |
| 06/08/2011 | CN101366806B Method of preparing balsam pear freeze-dried powder |
| 06/08/2011 | CN101328152B Piperazidine compound and pyridine compound |
| 06/08/2011 | CN101288691B Chinese medicinal extracts for treating 'two high, one low', capsules and preparation method thereof |
| 06/08/2011 | CN101272774B Substituted acrylamide derivative and pharmaceutical composition comprising the same |
| 06/08/2011 | CN101209085B Feed capable of reducing body fat and mortality rate of chicken and breeding method therewith |
| 06/08/2011 | CN101190013B Formula of honey crisp-fried bean and processing method |
| 06/08/2011 | CN101185481B Elver nuisance free swelling particle formula feed |
| 06/08/2011 | CN101181446B Application of sitsang scindapsus aureus flower as well as extract thereof in the preparation of diabetes medicament |
| 06/08/2011 | CN101084971B Method for preparing total saponins of platycodon grandiflorum |